American Portfolios Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

American Portfolios Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,600	Closed	-$410	–	2683
2018 Q4	$410	Sell	3,600 -7,000	-66%	-$4.59K	﹤0.01%	2321
2018 Q3	$18K	Buy	10,600 +2,550	+32%	+$4.56K	﹤0.01%	1520
2018 Q2	$14K	Buy	8,050 +2,450	+44%	+$4.24K	﹤0.01%	1587
2018 Q1	$10.2K	Buy	5,600 +5,000	+833%	+$10.6K	﹤0.01%	1629
2017 Q4	$1.34K	Buy	+600	New	+$1.49K	﹤0.01%	2115

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

American Portfolios Advisors's SGYP Position: Q1 2019 in Review

American Portfolios Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 3,600 shares — an estimated $410 sold.

American Portfolios Advisors first reported a position in SGYP in Q4 2017 and held it in 5 quarters. The position peaked at $18K in Q3 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

American Portfolios Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
American Portfolios Advisors sold 3,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $410.
American Portfolios Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 5 quarters.
American Portfolios Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $18K in Q3 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on American Portfolios Advisors's 13F filing for Q1 2019, filed 24 Mar 2023.